Perrigo Company will acquire the assets of Minneapolis-based generic pharmaceutical products manufacturer, Paddock Laboratories. The U.S. global healthcare supplier will pay a total of about $540 million for the acquisition. The buyer may fund the transaction with $80 million of cash on hand, $310 million of its existing bank debt and $150 million from a new term loan from Morgan Stanley, JPMorgan and Bank of America. Morgan Stanley is the financial advisor to Perrigo, while Paddock will be advised by Jefferies and Greene Holcomb & Fisher.

Click here for the release from PR Newswire.